JP2009528517A5 - - Google Patents

Download PDF

Info

Publication number
JP2009528517A5
JP2009528517A5 JP2008556622A JP2008556622A JP2009528517A5 JP 2009528517 A5 JP2009528517 A5 JP 2009528517A5 JP 2008556622 A JP2008556622 A JP 2008556622A JP 2008556622 A JP2008556622 A JP 2008556622A JP 2009528517 A5 JP2009528517 A5 JP 2009528517A5
Authority
JP
Japan
Prior art keywords
sample
patient
alzheimer
disease
dementia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008556622A
Other languages
English (en)
Japanese (ja)
Other versions
JP5496513B2 (ja
JP2009528517A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2007/000313 external-priority patent/WO2007098585A1/en
Publication of JP2009528517A publication Critical patent/JP2009528517A/ja
Publication of JP2009528517A5 publication Critical patent/JP2009528517A5/ja
Application granted granted Critical
Publication of JP5496513B2 publication Critical patent/JP5496513B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008556622A 2006-02-28 2007-02-28 認知症及び他の神経障害の診断方法 Active JP5496513B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US77729006P 2006-02-28 2006-02-28
US60/777,290 2006-02-28
US80477906P 2006-06-14 2006-06-14
US60/804,779 2006-06-14
US88888307P 2007-02-08 2007-02-08
US60/888,883 2007-02-08
PCT/CA2007/000313 WO2007098585A1 (en) 2006-02-28 2007-02-28 Methods for the diagnosis of dementia and other neurological disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012169181A Division JP2012255793A (ja) 2006-02-28 2012-07-31 認知症及び他の神経障害の診断方法

Publications (3)

Publication Number Publication Date
JP2009528517A JP2009528517A (ja) 2009-08-06
JP2009528517A5 true JP2009528517A5 (enExample) 2010-04-15
JP5496513B2 JP5496513B2 (ja) 2014-05-21

Family

ID=38458611

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008556622A Active JP5496513B2 (ja) 2006-02-28 2007-02-28 認知症及び他の神経障害の診断方法
JP2012169181A Pending JP2012255793A (ja) 2006-02-28 2012-07-31 認知症及び他の神経障害の診断方法
JP2014131876A Pending JP2014197018A (ja) 2006-02-28 2014-06-26 認知症及び他の神経障害の診断方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012169181A Pending JP2012255793A (ja) 2006-02-28 2012-07-31 認知症及び他の神経障害の診断方法
JP2014131876A Pending JP2014197018A (ja) 2006-02-28 2014-06-26 認知症及び他の神経障害の診断方法

Country Status (11)

Country Link
US (2) US8304246B2 (enExample)
EP (3) EP1922325B1 (enExample)
JP (3) JP5496513B2 (enExample)
KR (1) KR20080104350A (enExample)
AT (1) ATE535535T1 (enExample)
AU (1) AU2007219666A1 (enExample)
CA (2) CA2689848A1 (enExample)
HK (1) HK1208467A1 (enExample)
IL (1) IL193426A0 (enExample)
NZ (1) NZ570413A (enExample)
WO (1) WO2007098585A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007346587C1 (en) 2007-02-08 2015-01-22 Med-Life Discoveries Lp Methods for the treatment of Senile Dementia of the Alzheimer's Type
CN101675337A (zh) 2007-04-13 2010-03-17 菲诺梅诺米发现公司 用于缩醛磷脂缺乏介导的衰老疾病的诊断和危险评估的方法
AU2008280806B2 (en) * 2007-07-26 2014-12-11 Phenomenome Discoveries Inc. Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders
SG10201704689XA (en) 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
US20140365895A1 (en) 2008-05-13 2014-12-11 Apple Inc. Device and method for generating user interfaces from a template
US9121844B1 (en) * 2008-09-09 2015-09-01 Sociedad Europea de Analisis Diferencial de Movilidad Method to analyze and classify persons and organisms based on odor patterns from released vapors
TWI475989B (zh) 2008-12-22 2015-03-11 Phenomenome Discoveries Inc 縮醛磷脂類化合物，含彼之醫藥組成物以及治療老化疾病的方法
SG10201405975VA (en) 2009-10-01 2014-11-27 Phenomenome Discoveries Inc Serum-based biomarkers of pancreatic cancer and uses thereof for diseasedetection and diagnosis
SG10201505723UA (en) 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
MX2013000917A (es) 2010-07-23 2013-07-05 Harvard College Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
CN103314291B (zh) * 2010-12-28 2016-05-11 藤野脑研究株式会社 通过血液样品判定痴呆症用的检验方法
CA2812129C (en) * 2011-11-17 2014-10-21 Phenomenome Discoveries Inc. Methods for the synthesis of 13c labeled plasmalogen
WO2013119651A1 (en) * 2012-02-08 2013-08-15 Nestec Sa Methods for diagnosing cognitive impairment
CA2863184A1 (en) * 2012-02-15 2013-08-22 Basf Se Means and methods for assessing neuronal toxicity
CN104246781B (zh) * 2012-03-29 2019-06-14 皇家飞利浦有限公司 用于改进神经科医师的关于阿尔茨海默氏病的工作流程的系统与方法
EA201590024A1 (ru) 2012-06-15 2015-05-29 Гарри Стилли Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток
CN104603289A (zh) 2012-06-15 2015-05-06 哈里·斯泰利 检测疾病或病状的方法
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2014197339A1 (en) 2013-06-08 2014-12-11 Apple Inc. Device, method, and graphical user interface for synchronizing two or more displays
WO2015071145A1 (en) * 2013-11-14 2015-05-21 Nestec S.A. Lipid biomarkers of healthy ageing
US20160235778A1 (en) * 2014-03-13 2016-08-18 Massachusetts Institute Of Technology Compositions containing pufa, uridine and choline and methods of use thereof
EP4428251A3 (en) 2014-09-11 2024-12-18 Immunis.AI, Inc. Methods of detecting prostate cancer
US10006925B2 (en) 2016-05-30 2018-06-26 Universal Diagnostics, S. L. Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps
GB201611596D0 (en) * 2016-07-04 2016-08-17 British American Tobacco Investments Ltd Apparatus and method for classifying a tobacco sample into one of a predefined set of taste categories
WO2018157013A1 (en) * 2017-02-24 2018-08-30 Duke University Compositions and methods related to sex-specific metabolic drivers in alzheimer's disease
EP3684463B1 (en) 2017-09-19 2025-05-14 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US12280219B2 (en) 2017-12-31 2025-04-22 NeuroLight, Inc. Method and apparatus for neuroenhancement to enhance emotional response
US11318277B2 (en) 2017-12-31 2022-05-03 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
EP3811245A4 (en) 2018-06-19 2022-03-09 Ellipsis Health, Inc. MENTAL HEALTH ASSESSMENT SYSTEMS AND METHODS
JP7389421B2 (ja) * 2018-07-13 2023-11-30 Ｐｓｔ株式会社 精神・神経系疾患を推定する装置
US11452839B2 (en) 2018-09-14 2022-09-27 Neuroenhancement Lab, LLC System and method of improving sleep
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
WO2022263927A2 (en) * 2021-06-17 2022-12-22 Phoska Biopharma Pte. Ltd. Plasmalogen derivatives and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009371A1 (en) * 1992-10-09 1994-04-28 Massachusetts Institute Of Technology Antemortem diagnostic test for alzheimer's disease
US5731354A (en) * 1996-05-06 1998-03-24 Clarion Pharmaceuticals Inc. Treatment for the inhibition of neuro-degenerative disease states
US6177476B1 (en) * 1998-08-27 2001-01-23 Clarion Pharmaceuticals Inc. Nutritional supplements for replenishing plasmalogens
CA2298181C (en) 2000-02-02 2006-09-19 Dayan Burke Goodnough Non-targeted complex sample analysis
WO2001078652A2 (en) 2000-04-14 2001-10-25 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
EP1317765A2 (en) * 2000-09-08 2003-06-11 Oxford GlycoSciences (UK) Limited Automated identification of peptides
CA2446886A1 (en) * 2001-04-06 2002-10-17 Biovision Ag Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
US7202044B2 (en) 2001-05-09 2007-04-10 Biovision Ag Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection agents
CA2745724C (en) 2002-08-23 2015-06-02 Bayer Schering Pharma Aktiengesellschaft Biomarkers comprising peptide sequence vnhvtlsqpk for diagnosing alzheimer's disease
US7794948B2 (en) 2003-11-07 2010-09-14 Vermilllion, Inc. Biomarkers for alzheimer's disease
WO2005085838A2 (en) * 2004-03-02 2005-09-15 Vanderbilt University Computational analysis of mass spectroscopic lipid data
WO2005116659A2 (en) * 2004-05-18 2005-12-08 Neurodx, Llc Compositions and methods relating to alzheimer’s disease
JP4176749B2 (ja) * 2005-07-29 2008-11-05 学校法人帝京大学 疾病検査法
US8026099B2 (en) * 2007-07-26 2011-09-27 Washington University Lipid profile as a biomarker for early detection of neurological disorders

Similar Documents

Publication Publication Date Title
Paglia et al. Ion mobility mass spectrometry in the omics era: Challenges and opportunities for metabolomics and lipidomics
Nambiar et al. Metabolomics in chronic lung diseases
Mishur et al. Applications of mass spectrometry to metabolomics and metabonomics: Detection of biomarkers of aging and of age‐related diseases
JP5496513B2 (ja) 認知症及び他の神経障害の診断方法
JP2009530624A5 (enExample)
CN109239210B (zh) 一种胰腺导管腺癌标志物及其筛选方法
CA2680748C (en) Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging
BRPI0709176A2 (pt) biomarcadores úteis para diagnosticar o cáncer de próstata e seus métodos
JP2013525801A5 (enExample)
US20050101023A1 (en) Methods for diagnosing urinary tract and prostatic disorders
US20120322088A1 (en) Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders
Mill et al. Recent advances in understanding of Alzheimer’s disease progression through mass spectrometry-based metabolomics
Gagnebin et al. Toward a better understanding of chronic kidney disease with complementary chromatographic methods hyphenated with mass spectrometry for improved polar metabolome coverage
Mashmoushi et al. Rapid separation of cannabinoid isomer sets using differential mobility spectrometry and mass spectrometry
Hsu et al. Urinary exposure marker discovery for toxicants using ultra-high pressure liquid chromatography coupled with Orbitrap high resolution mass spectrometry and three untargeted metabolomics approaches
CN112964807B (zh) 乙肝慢加急性肝衰竭预后的代谢标记物及其筛选方法
Guinan et al. Porous silicon mass spectrometry as an alternative confirmatory assay for compliance testing of methadone
Das et al. Biomarkers in disease diagnosis and monitoring: insights into clinical applications and mass spectrometry-based detection
CN104280478B (zh) 内源性小分子物质在快速检测肾毒性方面的应用
WO2018007422A1 (en) Identification of human non-alcoholic fatty liver disease (nafld) subtypes
CN104297442B (zh) 内源性小分子物质在快速检测早期心脏毒性方面的应用
Sarkar et al. Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases
CN101395163A (zh) 诊断痴呆和其它神经病症的方法
EP4427045A1 (en) Method for the diagnosis of melanoma
CN116027041A (zh) 口腔癌辅助诊断标志物、试剂盒及其应用